Literature DB >> 20874839

CD10-bearing fibroblast inhibits matrigel invasive potency of interleukin-1α-producing squamous cell carcinoma by diminishing substance P levels in the tumor microenvironment.

Lining Xie1, Yoichi Moroi, Gaku Tsuji, Min Liu, Sayaka Hayashida, Masakazu Takahara, Shuji Fukagawa, Satoshi Takeuchi, Baoen Shan, Takeshi Nakahara, Hiroshi Uchi, Takehiko Yokomizo, Masutaka Furue.   

Abstract

CD10 is a neutral endopeptidase, which cleaves various peptide substrates including substance P. CD10 expression has been detected in peritumoral fibroblasts (Fb) within the invasive area of various cancers such as squamous cell carcinoma (SCC). However, the biological significance of CD10-bearing Fb remains largely unknown. We examined dynamic interactions of Fb with tumorigenic A431 SCC cells or non-tumorigenic HaCaT squamous cells. The SCC and HaCaT cells did not synthesize CD10, while Fb constitutively expressed CD10. When co-cultured, SCC markedly upregulated fibroblastic CD10 expression compared with HaCaT, which was mainly attributable to SCC-derived interleukin-1α (IL-1α). Both SCC and Fb autonomously secreted substance P, which eventually enhanced the invasive capacity of SCC in a matrigel invasion assay by upregulating matrix metalloproteinase (MMP)-1 and MMP-2, but not MMP-9. Transfection of siRNA for CD10 successfully knocked down the CD10 expression in Fb (CD10ND-Fb). In the presence of CD10ND-Fb, substance P levels in supernatants as well as MMP production and the invasive potency of SCC were significantly augmented compared with control scramble RNA-transfected Fb. We also transfected CD10 vector to Fb and found that the matrigel invasive ability of SCC cells was downregulated co-cultured with CD10 vector-transfected Fb rather than empty vector-transfected Fb. In conclusion, the CD10-bearing Fb generated by SCC-derived IL-1 inhibited the invasive capacity of SCC by diminishing the microenvironmental concentration of substance P.
© 2010 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874839     DOI: 10.1111/j.1349-7006.2010.01735.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  6 in total

1.  The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development.

Authors:  Tae Jung Jang; Jeong Bae Park; Jong Im Lee
Journal:  Korean J Pathol       Date:  2013-08-26

Review 2.  Regulation of Carcinogenesis by Sensory Neurons and Neuromediators.

Authors:  Nuray Erin; Galina V Shurin; James H Baraldi; Michael R Shurin
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

3.  CD10 Is Again Expressed at a Certain Stage during the Neoplastic Process of Bladder Transitional Cell Carcinomas.

Authors:  Tae Jung Jang
Journal:  Cancer Res Treat       Date:  2012-12-31       Impact factor: 4.679

4.  Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.

Authors:  Fariba Mohammadi; Hossein Javid; Amir Reza Afshari; Baratali Mashkani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2020-05-20       Impact factor: 2.316

5.  Comparison of immunohistochemical expression of CD10 in keratocystic odontogenic tumor and ameloblastoma.

Authors:  Elham Hormozi; Vahid Nourollahi Fard; Mohammad Ali Naseri; Nima Haghighat Jahromi; Forooz Keshani
Journal:  Dent Res J (Isfahan)       Date:  2016 Mar-Apr

6.  CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.

Authors:  Junna Oba; Takeshi Nakahara; Akiko Hashimoto-Hachiya; Min Liu; Takeru Abe; Akihito Hagihara; Takehiko Yokomizo; Masutaka Furue
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.